GRIA3 and migraine disorder: Moreover, we have recently found that a glutamatergic polymorphism, Glutamate receptor ionotropic AMPA 3 (GRIA3), already known to be related to central sensitization mechanism and then to migraine pathophysiology, can also influence neurophysiologic features of chronic migraine due to medication overuse.